Cited by

• A Qualitative Study Exploring Perceptions to the Human T Cell Leukaemia Virus Type 1 in Central Australia: Barriers to Preventing Transmission in a Remote Aboriginal Population.

  Fowler F, Einsiedel L. Fowler F, et al. Front Med (Lausanne). 2022 Apr 29;9:845594. doi: 10.3389/fmed.2022.845594. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572972 Free PMC article.
• Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

  Legrand N, McGregor S, Bull R, Bajis S, Valencia BM, Ronnachit A, Einsiedel L, Gessain A, Kaldor J, Martinello M. Legrand N, et al. Clin Microbiol Rev. 2022 Apr 20;35(2):e0007821. doi: 10.1128/cmr.00078-21. Epub 2022 Feb 23. Clin Microbiol Rev. 2022. PMID: 35195446 Free PMC article. Review.
• Very high prevalence of infection with the human T cell leukaemia virus type 1c in remote Australian Aboriginal communities: Results of a large cross-sectional community survey.

  Einsiedel L, Pham H, Talukder MR, Taylor K, Wilson K, Kaldor J, Gessain A, Woodman R. Einsiedel L, et al. PLoS Negl Trop Dis. 2021 Dec 8;15(12):e0009915. doi: 10.1371/journal.pntd.0009915. eCollection 2021 Dec. PLoS Negl Trop Dis. 2021. PMID: 34879069 Free PMC article.
• Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study.

  Einsiedel L, Woodman RJ, Flynn M, Wilson K, Cassar O, Gessain A. Einsiedel L, et al. BMC Public Health. 2016 Aug 15;16:787. doi: 10.1186/s12889-016-3366-5. BMC Public Health. 2016. PMID: 27526923 Free PMC article.
• A Caucasian Australian presenting with human T-lymphotropic virus type I associated myelopathy: a case report.

  Faull M, Panegyres PK. Faull M, et al. J Med Case Rep. 2014 Nov 23;8:382. doi: 10.1186/1752-1947-8-382. J Med Case Rep. 2014. PMID: 25416840 Free PMC article.